Who Should Receive Extended Infusion Beta-Lactam Therapy?Journal of the American Academy of Physician Assistants
AbstractThe increasing prevalence of antibiotic-resistant bacteria challenges a clinician's ability to fight life-threatening infections. Administering beta-lactams via extended infusion may improve patient outcomes. This article discusses the underlying principles of this therapeutic approach and when it may be appropriate.
RightsVersion of record can be found through LWW.
Citation InformationChristopher T. Roman, Tia Sloth and Kendra M. Damer. "Who Should Receive Extended Infusion Beta-Lactam Therapy?" Journal of the American Academy of Physician Assistants Vol. 29 Iss. 3 (2016) p. 25 - 26
Available at: http://works.bepress.com/kendra-damer/1/